• FAQs
  • Glossary
Close

FAQs

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

See full Glossary

Ethics and Society

Resources & Factsheets

EuroGCT Resource
DNA teaser

What are 'unproven' therapies?

Related Topics Clinical Trials Current and Potential Uses Ethics and Society Factsheets MSCs Policy & Regulation Unproven Treatments
English
EuroGCT Resource
Image of a cluster of embryonic stem cells

Ethical questions in embryonic stem cell research

Related Topics Current and Potential Uses Embryonic Stem Cells Ethics and Society
English

Growing support for gene and cell therapies in Germany

Related Topics Cell Therapy Ethics and Society Gene Therapy Policy & Regulation
The Genetic Shambles logo

Genetics Shambles

Related Topics Cell and Gene Fundamentals Ethics and Society Explore Stem Cells Gene Editing Gene Therapy Research
European Huntington's Association logo

International Guidelines for the Treatment of Huntington's Disease

Related Topics Huntington's Disease Neurological Disorders Current and Potential Uses Ethics and Society
Alzheimer's Society UK logo

Alzheimer's Society UK: Legal and financial issues for people living with dementia in the UK

Related Topics Alzheimer's Disease Neurological Disorders Ethics and Society
EuroGCT Resource

Where should I start?

Related Topics Cell and Gene Fundamentals Cell Therapy Clinical Trials Current and Potential Uses Ethics and Society Gene Therapy Methods and Tools Patient Involvement Policy & Regulation Research
EuroGCT Resource

There is an approved treatment available for my condition - why can't I receive it?

Related Topics Rare Diseases Clinical Trials Current and Potential Uses Ethics and Society Industry Policy & Regulation Unproven Treatments

ATMP Engage working groups

Related Topics Ethics and Society Patient Involvement Policy & Regulation
EuroGCT Resource
EuroGCT stock DNA graphic

Why are some conditions more suitable for gene and cell therapies than others?

Related Topics Cell Therapy Clinical Trials Current and Potential Uses Disease Modelling Ethics and Society Gene Editing Gene Therapy Methods and Tools Patient Involvement Policy & Regulation Research
Back to top